Print Options
PrintThe Whole
Instrument
PrintThe Whole
Schedule
PrintThe Whole
Part
Status:
Point in time view as at 08/04/2005.
Changes to legislation:
There are currently no known outstanding effects for the The Blood Safety and Quality Regulations 2005.
Changes to Legislation
Revised legislation carried on this site may not be fully up to date. At the current time any known changes or effects made by subsequent legislation have been applied to the text of the legislation you are viewing by the editorial team. Please see ‘Frequently Asked Questions’ for details regarding the timescales for which new effects are identified and recorded on this site.
However, the following deferral periods shall apply for the infections listed in the table:
Brucellosis (*) | 2 years following the date of full recovery |
Osteomyelitis | 2 years after confirmed cured |
Q fever (*) | 2 years following the date of confirmed cure |
Syphilis (*) | 1 year following the date of confirmed cure |
Toxoplasmosis (*) | 6 months following the date of clinical recovery |
Tuberculosis | 2 years following the date of confirmed cure |
Rheumatic fever | 2 years following the date of cessation of symptoms, unless evidence of chronic heart disease |
| 2 weeks following the date of cessation of symptoms |
Flu-like illness | 2 weeks after cessation of symptoms |
| |
— individuals who have lived in a malarial area within the first five years of life | 3 years following return from last visit to any endemic area, provided person remains symptom free;
may be reduced to 4 months if an immunologic or molecular genomic test is negative at each donation.
|
— individuals with a history of malaria | 3 years following cessation of treatment and absence of symptoms.
Donations may be accepted thereafter only if an immunologic or molecular genomic test is negative
|
— asymptomic visitors to endemic areas | 6 months after leaving the endemic area unless an immunologic or molecular genomic test is negative |
— individuals with a history of undiagnosed febrile illness during or within six months of a visit to an endemic area | 3 years following resolution of symptoms;
may be reduced to 4 months if an immunologic or molecular test is negative
|
West Nile Virus (WNV) (*) | 28 days after leaving an area with ongoing transmission of WNV to humans |
Yn ôl i’r brig